{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T19:13:01Z","timestamp":1677093181051},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11,1]]},"DOI":"10.1093\/chromsci\/bmt171","type":"journal-article","created":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T01:58:46Z","timestamp":1386035926000},"page":"1294-1301","source":"Crossref","is-referenced-by-count":5,"title":["Development of a Validated Stability-Indicating HPTLC Method for Rufinamide in Bulk and Its Pharmaceutical Dosage Form"],"prefix":"10.1093","volume":"52","author":[{"given":"Apexa","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpit","family":"Patwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhanubhai","family":"Suhagia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,12,1]]},"reference":[{"key":"key\n\t\t\t\t20171011142502_BMT171C1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1535-7511.2009.01336.x","article-title":"Rufinamide: a novel broad-spectrum antiepileptic drug","volume":"10","author":"Wheless","year":"2010","journal-title":"Epilepsy Currents"},{"key":"key\n\t\t\t\t20171011142502_BMT171C2","first-page":"855","article-title":"Rufinamide: a novel antiepileptic drug","volume":"2","author":"Patel","year":"2011","journal-title":"Research Journal of Pharmaceutical, Biological and Chemical Sciences"},{"key":"key\n\t\t\t\t20171011142502_BMT171C3","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1528-1167.2008.01552.x","article-title":"The anticonvulsant profile of rufinamide (CGP33101) in rodent seizure models","volume":"49","author":"White","year":"2008","journal-title":"Epilepsia"},{"key":"key\n\t\t\t\t20171011142502_BMT171C4","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000303813.95800.0d","article-title":"Rufinamide for generalized seizures associated with Lennox\u2013Gastaut Syndrome","volume":"70","author":"Glauser","year":"2008","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20171011142502_BMT171C5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jchromb.2009.11.039","article-title":"Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy","volume":"878","author":"Contin","year":"2010","journal-title":"Journal of Chromatography B"},{"key":"key\n\t\t\t\t20171011142502_BMT171C6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00216-011-5126-9","article-title":"Development and validation of an HPLC-UV detection assay for the determination of rufinamide in human plasma and saliva","volume":"401","author":"Mazzucchelli","year":"2011","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"key\n\t\t\t\t20171011142502_BMT171C7","first-page":"9","article-title":"Development and validation of RP-HPLC method for estimation of rufinamide in bulk and its pharmaceutical dosage form","volume":"2","author":"Muneer","year":"2012","journal-title":"International Journal of Pharmaceutical Research and Analysis"},{"key":"key\n\t\t\t\t20171011142502_BMT171C8","first-page":"501","article-title":"New stability indicating liquid chromatographic method for the determination of rufinamide in presence of degradant products","volume":"4","author":"Annapurna","year":"2012","journal-title":"Drug Invention Today"},{"key":"key\n\t\t\t\t20171011142502_BMT171C9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jpba.2010.07.015","article-title":"Rapid assay of rufinamide in dried blood spots by a new liquid chromatography\u2013tandem mass spectrometric method","volume":"54","author":"Giancarlo","year":"2011","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"key\n\t\t\t\t20171011142502_BMT171C10","article-title":"Development and validation of a stability indicating RP-HPLC method for the determination of rufinamide: stability-indicating RP-HPLC method for the determination of rufinamide","author":"Sai","year":"2012","journal-title":"Journal of Pharmaceutical Analysis"}],"container-title":["Journal of Chromatographic Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/chromsci\/article-pdf\/52\/10\/1294\/882893\/bmt171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T18:25:08Z","timestamp":1507746308000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/chromsci\/article\/52\/10\/1294\/310863\/Development-of-a-Validated-StabilityIndicating"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,1]]},"references-count":10,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,12,1]]},"published-print":{"date-parts":[[2014,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/chromsci\/bmt171","relation":{},"ISSN":["1945-239X","0021-9665"],"issn-type":[{"value":"1945-239X","type":"electronic"},{"value":"0021-9665","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,11]]},"published":{"date-parts":[[2013,12,1]]}}}